Design Therapeutics Net Debt Growth & History (DSGN)

Design Therapeutics's net debt was −$15.3M for fiscal 2025.

View full Design Therapeutics company overview

Design Therapeutics annual net debt history

Design Therapeutics annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$15.3M$4.9M
20242024-12-31−$20.2M−$2.1M
20232023-12-31−$18.1M$4.7M
20222022-12-31−$22.8M$272.1M
20212021-12-31−$294.9M

Design Therapeutics net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Design Therapeutics's net debt increased from −$294.9M to −$15.3M, a change of $279.6M. The latest reported quarter, Q2 2026, shows −$10.2M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Design Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about DSGN yet. Start the conversation.

Write the first post